Nebula Research & Development’s Amneal Pharmaceuticals AMRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $984K | Buy |
121,599
+65,236
| +116% | +$528K | 0.08% | 406 |
|
|
2025
Q1 | $472K | Buy |
56,363
+9,851
| +21% | +$82.6K | 0.04% | 625 |
|
|
2024
Q4 | $368K | Buy |
+46,512
| New | +$368K | 0.04% | 656 |
|
|
2024
Q3 | – | Sell |
-119,284
| Closed | -$757K | – | 922 |
|
|
2024
Q2 | $757K | Buy |
119,284
+22,501
| +23% | +$143K | 0.12% | 297 |
|
|
2024
Q1 | $587K | Buy |
96,783
+55,589
| +135% | +$337K | 0.13% | 304 |
|
|
2023
Q4 | $250K | Buy |
41,194
+28,155
| +216% | +$171K | 0.08% | 487 |
|
|
2023
Q3 | $55K | Buy |
+13,039
| New | +$55K | 0.03% | 472 |
|